Objectives: Serum autoantibodies are pivotal for the early detection of systemic autoimmune rheumatic diseases such as Systemic Sclerosis (SSc) and Poly/Dermatomyositis (PM/DM), and in some cases are associated with organ complications such as interstitial lung disease (ILD). A paradigmatic example is provided by the autoantibody against the Eukaryotic Initiation Factor 2B (eIF2B) that has been recently detected in SSc. Methods: Sera from 118 patients with SSc, 8 Poly/Dermatomyositis, 2 overlap SSc/Polymyositis, 4 undifferentiated connective tissue disease-UCTD and 3 healthy controls were tested first by indirect immunofluorescence for anti-nuclear antibodies-ANA pattern. Further, we employed prot ein-radioimmunoprecipitation (IP) and IP- W...
BACKGROUND: Interstitial lung disease (ILD) is the most common cause of death in patients with syste...
International audienceABSTRACT: INTRODUCTION: Antinuclear antibodies (ANA), usually detected by indi...
Objectives: To determine prevalence and co-existence of myositis specific autoantibodies (MSAs) and ...
Objective Anti-nuclear autoantibodies are known to occur in 85-99% of Systemic Sclerosis (SSc) patie...
Autoanticuerpos; Trastornos reumáticos autoinmunes; Enfermedad pulmonar intersticialAutoanticossos; ...
Anti-cyclic citrullinated peptide antibody testing is used to diagnose rheumatoid arthritis and asso...
Disease-specific autoantibodies are considered the most important biomarkers for systemic sclerosis ...
BACKGROUND: Autoantibody detection has been assessed as tool for the diagnosis and the definition o...
Systemic sclerosis (SSc) is an autoimmune disease characterized by vascular abnormalities, and cutan...
The role of autoantibody testing for patients with interstitial lung disease is an evolving area. Re...
OBJECTIVE: To evaluate clinical associations of anti-PM/Scl antibodies in patients with Systemic Scl...
Objective: To identify auto-antibodies in systemic sclerosis with interstitial lung disease (ILD). ...
SummaryBackgroundInterstitial lung disease (ILD) is a common extramuscular manifestation of the idio...
The identification of serum autoantibodies is central in the diagnosis of systemic autoimmune rheuma...
The presence of interstitial lung disease (ILD) is a common and fearsome feature of idiopathic infla...
BACKGROUND: Interstitial lung disease (ILD) is the most common cause of death in patients with syste...
International audienceABSTRACT: INTRODUCTION: Antinuclear antibodies (ANA), usually detected by indi...
Objectives: To determine prevalence and co-existence of myositis specific autoantibodies (MSAs) and ...
Objective Anti-nuclear autoantibodies are known to occur in 85-99% of Systemic Sclerosis (SSc) patie...
Autoanticuerpos; Trastornos reumáticos autoinmunes; Enfermedad pulmonar intersticialAutoanticossos; ...
Anti-cyclic citrullinated peptide antibody testing is used to diagnose rheumatoid arthritis and asso...
Disease-specific autoantibodies are considered the most important biomarkers for systemic sclerosis ...
BACKGROUND: Autoantibody detection has been assessed as tool for the diagnosis and the definition o...
Systemic sclerosis (SSc) is an autoimmune disease characterized by vascular abnormalities, and cutan...
The role of autoantibody testing for patients with interstitial lung disease is an evolving area. Re...
OBJECTIVE: To evaluate clinical associations of anti-PM/Scl antibodies in patients with Systemic Scl...
Objective: To identify auto-antibodies in systemic sclerosis with interstitial lung disease (ILD). ...
SummaryBackgroundInterstitial lung disease (ILD) is a common extramuscular manifestation of the idio...
The identification of serum autoantibodies is central in the diagnosis of systemic autoimmune rheuma...
The presence of interstitial lung disease (ILD) is a common and fearsome feature of idiopathic infla...
BACKGROUND: Interstitial lung disease (ILD) is the most common cause of death in patients with syste...
International audienceABSTRACT: INTRODUCTION: Antinuclear antibodies (ANA), usually detected by indi...
Objectives: To determine prevalence and co-existence of myositis specific autoantibodies (MSAs) and ...